Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 27.14 CNY 0.3%
Market Cap: 69.4B CNY
Have any thoughts about
Shanghai Fosun Pharmaceutical Group Co Ltd?
Write Note

Shanghai Fosun Pharmaceutical Group Co Ltd
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shanghai Fosun Pharmaceutical Group Co Ltd
Pre-Tax Income Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Pre-Tax Income
ÂĄ2.5B
CAGR 3-Years
-24%
CAGR 5-Years
-7%
CAGR 10-Years
-1%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Pre-Tax Income
ÂĄ3.8B
CAGR 3-Years
7%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Pre-Tax Income
ÂĄ3.6B
CAGR 3-Years
16%
CAGR 5-Years
19%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Pre-Tax Income
ÂĄ5.9B
CAGR 3-Years
-5%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Pre-Tax Income
ÂĄ5.2B
CAGR 3-Years
-6%
CAGR 5-Years
7%
CAGR 10-Years
6%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Pre-Tax Income
-ÂĄ769m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Pre-Tax Income?
Pre-Tax Income
2.5B CNY

Based on the financial report for Jun 30, 2024, Shanghai Fosun Pharmaceutical Group Co Ltd's Pre-Tax Income amounts to 2.5B CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
-1%

Over the last year, the Pre-Tax Income growth was -48%. The average annual Pre-Tax Income growth rates for Shanghai Fosun Pharmaceutical Group Co Ltd have been -24% over the past three years , -7% over the past five years , and -1% over the past ten years .

Back to Top